XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure      
Pay vs Performance Disclosure, Table
Pay versus Performance Table
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
Year(1)
Summary
Compensation
Table Total
for Principal
Executive
Officer
(“PEO”) 1
(2)
($)
Compensation
Actually Paid
to PEO 1
(3)
($)
Summary
Compensation
Table Total
for PEO 2
(2)
($)
Compensation
Actually Paid
to PEO 2
(3)
($)
Average
Summary
Compensation
Table Total
for Non-PEO
Named
Executive
Officers
(“NEOs”)
(4)
($)
Average
Compensation
Actually Paid
to Non-PEO
NEOs
(5)
($)
Value of
Initial Fixed
$100
Investment
Based on
Total
Shareholder
Return
(“TSR”)
(6)
($)
Net Income(7)
(Thousands)
($)
2024
1,584,176 745,181 576,350 433,200 33 (18,916)
2023
1,133,931 1,421,104 634,140 578,496 316,267 357,361 58 (69,045)
2022
1,639,908 (347,905) 586,033 278,524 22 (36,917)
(1)
We are a smaller reporting company pursuant to Rule 405 of the Securities Act of 1933, and as such, we are only required to include information for the past three fiscal years in this table.
(2)
The dollar amounts reported in column (b) for the fiscal year 2024 is the amount of total compensation reported for Dr. Birx (“PEO 1”). The dollar amounts reported in columns (b) and (d) for the fiscal year 2023 is the amounts of total compensation reported for Dr. Birx (our Chief Executive Officer since July 10, 2023) (“PEO 1”) and Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 2”), respectively. The dollar amounts reported in columns (b) and (d) for the fiscal year 2022 are the amount of total compensation reported for Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 1”). Refer to “Executive Compensation - Summary Compensation Table” above.
(3)
The dollar amounts reported in columns (c) and (e) represent the amount of “compensation actually paid” to Dr. Birx and Dr. Varnum, respectively, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Dr. Birx and Dr. Varnum during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the adjustments made to Dr. Birx’s and Dr. Varnum’s total compensation for each year to determine the compensation actually paid are shown in the “Adjustments to Compensation Actually Paid” table below.
(4)
The dollar amounts reported in column (f) represent the average of the amounts reported for our Company’s named executive officers (other than Dr. Birx and Dr. Varnum) as a group (“NEOs”) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2024, Pierre Kyme, David House, Mina Pastagia, and Richard Rychlik; and (ii) for 2023, Richard Rychlik, Mina Pastagia and Erin Butler; (iii) for 2022, Mina Pastagia, Erin Butler and Steve Martin.
(5)
The dollar amounts reported in column (g) represent the average amount of “compensation actually paid” to the NEOs as a group, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the adjustments made to the average total compensation for the NEOs as a group for each year to determine the average compensation actually paid are shown in the “Adjustments to Compensation Actually Paid” table below.
(6)
Cumulative total shareholder return (“TSR”) is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between our Company’s share price at the end and the beginning of the measurement period (December 31, 2021) by our Company’s share price at the beginning of the measurement period. No dividends were paid on stock or option awards in 2022, 2023 or 2024.
(7)
The dollar amounts reported represent the amount of net income (loss) reflected in our audited financial statements for the applicable covered year.
Adjustments to Compensation Actually Paid
As noted above in footnotes 3 and 5 to the Pay versus Performance Table, in accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to (i) Dr. Birx and Dr. Varnum’s total compensation for each year, as applicable, to determine the compensation actually paid to each of them, and (ii) to the average total compensation for the NEOs as a group for each year to determine the average compensation actually paid to them. The methodology used to determine compensation actually paid is further described in footnotes (a), (b) and (c) below.
FY 2022
Adjustments:
PEO
Varnum
Other NEOs
Average
(c)
Total from Summary Compensation Table
$ 1,639,908 $ 586,033
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(904,908) (163,386)
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year(b)
297,600 53,733
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year(b)
(1,194,828) (156,767)
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year
(185,677) (41,089)
Total adjustments for stock and option awards
(1,987,813) (307,508)
Compensation Actually Paid (as calculated)
$ (347,905) $ 278,524
FY 2023
Adjustments:
PEO
Birx
PEO
Varnum
Other NEOs
Average
(c)
Total from Summary Compensation Table
$ 1,133,931 $ 634,140 $ 316,267
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(875,477) (33,087)
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year(b)
1,162,650 43,032
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year(b)
5,713 36,606
Add (Deduct): Change in fair value for awards granted in prior fiscal
years that vested in fiscal year
(b)
60,616 10,772
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal
year
(121,973) (16,229)
Total adjustments for stock and option awards
287,173 (55,644) 41,094
Compensation Actually Paid (as calculated)
$ 1,421,104 $ 578,496 $ 357,361
FY 2024
Adjustments:
PEO
Birx
Other NEOs
Average
(b)
Total from Summary Compensation Table
$ 1,584,176 $ 576,350
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(828,248) (137,225)
Add: Fair value of equity granted during fiscal year, outstanding and
unvested as of end of fiscal year
(b)
430,358 45,033
Add (Deduct): Change in fair value of equity granted in prior year that
is outstanding and unvested at the end of fiscal year
(b)
(386,807) (7,275)
Add (Deduct): Change in fair value for awards granted in prior fiscal
years that vested in fiscal year
(54,299) 4,366
(Deduct): The amount of fair value at the end of prior year for awards
granted in prior years that forfeited during the fiscal year
(48,049)
Total adjustments for stock and option awards
(838,996) (143,150)
Compensation Actually Paid (as calculated)
$ 745,181 $ 433,200
(a)
The grant date fair value of equity awards represents the sum of the totals of the amounts reported in the “Stock Awards” and/or “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year.
(b)
The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
(c)
For the NEOs as a group in each applicable year, all amounts shown represent averages.
   
Named Executive Officers, Footnote
(2)
The dollar amounts reported in column (b) for the fiscal year 2024 is the amount of total compensation reported for Dr. Birx (“PEO 1”). The dollar amounts reported in columns (b) and (d) for the fiscal year 2023 is the amounts of total compensation reported for Dr. Birx (our Chief Executive Officer since July 10, 2023) (“PEO 1”) and Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 2”), respectively. The dollar amounts reported in columns (b) and (d) for the fiscal year 2022 are the amount of total compensation reported for Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 1”). Refer to “Executive Compensation - Summary Compensation Table” above.
(4)
The dollar amounts reported in column (f) represent the average of the amounts reported for our Company’s named executive officers (other than Dr. Birx and Dr. Varnum) as a group (“NEOs”) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2024, Pierre Kyme, David House, Mina Pastagia, and Richard Rychlik; and (ii) for 2023, Richard Rychlik, Mina Pastagia and Erin Butler; (iii) for 2022, Mina Pastagia, Erin Butler and Steve Martin.
   
Adjustment To PEO Compensation, Footnote
FY 2022
Adjustments:
PEO
Varnum
Other NEOs
Average
(c)
Total from Summary Compensation Table
$ 1,639,908 $ 586,033
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(904,908) (163,386)
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year(b)
297,600 53,733
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year(b)
(1,194,828) (156,767)
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year
(185,677) (41,089)
Total adjustments for stock and option awards
(1,987,813) (307,508)
Compensation Actually Paid (as calculated)
$ (347,905) $ 278,524
FY 2023
Adjustments:
PEO
Birx
PEO
Varnum
Other NEOs
Average
(c)
Total from Summary Compensation Table
$ 1,133,931 $ 634,140 $ 316,267
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(875,477) (33,087)
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year(b)
1,162,650 43,032
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year(b)
5,713 36,606
Add (Deduct): Change in fair value for awards granted in prior fiscal
years that vested in fiscal year
(b)
60,616 10,772
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal
year
(121,973) (16,229)
Total adjustments for stock and option awards
287,173 (55,644) 41,094
Compensation Actually Paid (as calculated)
$ 1,421,104 $ 578,496 $ 357,361
FY 2024
Adjustments:
PEO
Birx
Other NEOs
Average
(b)
Total from Summary Compensation Table
$ 1,584,176 $ 576,350
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(828,248) (137,225)
Add: Fair value of equity granted during fiscal year, outstanding and
unvested as of end of fiscal year
(b)
430,358 45,033
Add (Deduct): Change in fair value of equity granted in prior year that
is outstanding and unvested at the end of fiscal year
(b)
(386,807) (7,275)
Add (Deduct): Change in fair value for awards granted in prior fiscal
years that vested in fiscal year
(54,299) 4,366
(Deduct): The amount of fair value at the end of prior year for awards
granted in prior years that forfeited during the fiscal year
(48,049)
Total adjustments for stock and option awards
(838,996) (143,150)
Compensation Actually Paid (as calculated)
$ 745,181 $ 433,200
(a)
The grant date fair value of equity awards represents the sum of the totals of the amounts reported in the “Stock Awards” and/or “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year.
(b)
The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
(c)
For the NEOs as a group in each applicable year, all amounts shown represent averages.
   
Non-PEO NEO Average Total Compensation Amount $ 576,350 $ 316,267 $ 586,033
Non-PEO NEO Average Compensation Actually Paid Amount $ 433,200 357,361 278,524
Adjustment to Non-PEO NEO Compensation Footnote
FY 2022
Adjustments:
PEO
Varnum
Other NEOs
Average
(c)
Total from Summary Compensation Table
$ 1,639,908 $ 586,033
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(904,908) (163,386)
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year(b)
297,600 53,733
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year(b)
(1,194,828) (156,767)
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year
(185,677) (41,089)
Total adjustments for stock and option awards
(1,987,813) (307,508)
Compensation Actually Paid (as calculated)
$ (347,905) $ 278,524
FY 2023
Adjustments:
PEO
Birx
PEO
Varnum
Other NEOs
Average
(c)
Total from Summary Compensation Table
$ 1,133,931 $ 634,140 $ 316,267
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(875,477) (33,087)
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year(b)
1,162,650 43,032
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year(b)
5,713 36,606
Add (Deduct): Change in fair value for awards granted in prior fiscal
years that vested in fiscal year
(b)
60,616 10,772
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal
year
(121,973) (16,229)
Total adjustments for stock and option awards
287,173 (55,644) 41,094
Compensation Actually Paid (as calculated)
$ 1,421,104 $ 578,496 $ 357,361
FY 2024
Adjustments:
PEO
Birx
Other NEOs
Average
(b)
Total from Summary Compensation Table
$ 1,584,176 $ 576,350
Adjustments for stock and options awards
Deduct: SCT Amounts(a)
(828,248) (137,225)
Add: Fair value of equity granted during fiscal year, outstanding and
unvested as of end of fiscal year
(b)
430,358 45,033
Add (Deduct): Change in fair value of equity granted in prior year that
is outstanding and unvested at the end of fiscal year
(b)
(386,807) (7,275)
Add (Deduct): Change in fair value for awards granted in prior fiscal
years that vested in fiscal year
(54,299) 4,366
(Deduct): The amount of fair value at the end of prior year for awards
granted in prior years that forfeited during the fiscal year
(48,049)
Total adjustments for stock and option awards
(838,996) (143,150)
Compensation Actually Paid (as calculated)
$ 745,181 $ 433,200
(a)
The grant date fair value of equity awards represents the sum of the totals of the amounts reported in the “Stock Awards” and/or “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year.
(b)
The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
(c)
For the NEOs as a group in each applicable year, all amounts shown represent averages.
   
Compensation Actually Paid vs. Total Shareholder Return
[MISSING IMAGE: bc_investment-4clr.jpg]
[MISSING IMAGE: bc_24investmenttsr-4c.jpg]
   
Compensation Actually Paid vs. Net Income
[MISSING IMAGE: bc_netloss-4clr.jpg]
[MISSING IMAGE: bc_24netloss-4c.jpg]
   
Total Shareholder Return Amount $ 33 58 22
Net Income (Loss) $ (18,916,000) (69,045,000) (36,917,000)
PEO Name Dr. Birx    
Dr. Birx [Member]      
Pay vs Performance Disclosure      
PEO Total Compensation Amount $ 1,584,176 1,133,931  
PEO Actually Paid Compensation Amount 745,181 1,421,104  
Dr. Varnum [Member]      
Pay vs Performance Disclosure      
PEO Total Compensation Amount 634,140 1,639,908
PEO Actually Paid Compensation Amount 578,496 (347,905)
PEO | Dr. Birx [Member] | Equity Awards Adjustments      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (838,996) 287,173  
PEO | Dr. Birx [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (828,248) (875,477)  
PEO | Dr. Birx [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 430,358 1,162,650  
PEO | Dr. Birx [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (386,807)  
PEO | Dr. Birx [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (54,299)  
PEO | Dr. Birx [Member] | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount  
PEO | Dr. Varnum [Member] | Equity Awards Adjustments      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   (55,644) (1,987,813)
PEO | Dr. Varnum [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   (904,908)
PEO | Dr. Varnum [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   297,600
PEO | Dr. Varnum [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   5,713 (1,194,828)
PEO | Dr. Varnum [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   60,616 (185,677)
PEO | Dr. Varnum [Member] | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   (121,973)  
Non-PEO NEO | Equity Awards Adjustments      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (143,150) 41,094 (307,508)
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (137,225) (33,087) (163,386)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 45,033 43,032 53,733
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (7,275) 36,606 (156,767)
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 4,366 10,772 $ (41,089)
Non-PEO NEO | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount $ (48,049) $ (16,229)